AP
The European Medicines Agency in London announced Wednesday it would review all drugs of this type in the wake of Merck & Co.'s decision to voluntarily withdraw Vioxx.
In the United States, a cardiologist who had researched these drugs published an article in the New England Journal of Medicine (news - web sites) suggesting problems might extend to the entire class of medications, not just Vioxx. Another prominent doctor writing in the same journal charged that the Food and Drug Administration (news - web sites) did not do everything needed to make sure the drug was safe. He also called for a congressional review of the matter.
More... |
